MTST (MetaStat) Stock Based Compensation: $0.65 Mil (TTM As of Feb. 2018)


What is MetaStat Stock Based Compensation?

MetaStat MTST Stock Based Compensation is $0.65 Mil as of Feb. 2018.

MetaStat's Stock Based Compensation for the three months ended in Feb. 2018 was $0.21 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Feb. 2018 was $0.65 Mil.

MetaStat Stock Based Compensation Related Terms

MetaStat Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for MetaStat's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaStat Stock Based Compensation Chart

MetaStat Annual Data
Trend Feb09 Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.95 1.33 0.82 0.64 0.65

MetaStat Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.07 0.06 0.31 0.21

MetaStat Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Feb. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.65 Mil.

What does a Stock Based Compensation of $0.65 Mil mean?
MetaStat (MTST) has a Stock Based Compensation of $0.65 Mil as of Feb. 2018. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MetaStat and its competitors.
Is MetaStat's Stock Based Compensation too high?
MetaStat's current Stock Based Compensation is $0.65 Mil.
How does MetaStat's Stock Based Compensation compare to OBMP and NSPX?
MetaStat's Stock Based Compensation of $0.65 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MetaStat and its competitors. MetaStat's current Stock Based Compensation is $0.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaStat stock overvalued right now?
MetaStat (MTST) has a current Stock Based Compensation of $0.65 Mil. The current Stock Based Compensation is $0.65 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For MetaStat (MTST), the current Stock Based Compensation is $0.65 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaStat Business Description

Address 27 Drydock Avenue, 2nd Floor, Boston, MA, USA, 02210
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.